Company
Investment-firm
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
IPO status
Contacts
location
Website URL
Similar Companies999
Brandon Capital Partners
Brandon Capital Partners is an Australian fund management business specializing in life science investments.
Sector
Subsector
Location
count Of Investments
count Of Exists
DKA Capital
DKA Capital is a Danish private equity fund that invests in and develops knowledge-intensive growth companies with global potential.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Galen Partners
Galen Partners is a leading healthcare venture capital firm based in Stamford, Connecticut.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
HighCape Partners
HighCape Partners invests in high-margin life sciences companies.
Sector
Subsector
Location
count Of Investments
count Of Exists
Financials
Investments20
Human Immunology Biosciences
Human Immunology Biosciences is a biotech firm that develops therapies for immune-mediated diseases.
Sector
Subsector
Keywords
Location
total rounds
total raised
NMD Pharma
NMD Pharma is a clinical-stage biotech company that develops novel treatments for neuromuscular disorders.
Sector
Subsector
Location
total rounds
total raised
Eyebiotech
Eyebiotech develops new therapies for eye diseases.
Sector
Subsector
Location
total rounds
total raised
Co-Investors
People
Founders1
Rafaele Tordjman
Managing Partner who specializes in life sciences investments. She joined Sofinnova Partners in 2001. Prior to this, she worked as a research scientist at the Institut National de la Recherche Médicale (INSERM) in Cochin Hospital, Paris. Before joining INSERM, she was a medical doctor specializing in clinical haematology and internal medicine. She obtained her PhD, with high honours, in haematopoiesis and angiogenesis from the University Paris VII followed by a post doctoral fellowship in immunology. Rafaèle obtained her medical degree and her specialisation in Haematology and Internal Medicine as a five-year fellow in Paris University Hospitals. She also participated in the “Young Manager Program” at INSEAD (France, in 2002). She has invested in and is on the board of Ascendis, DBV technologies [DBV:FP], Endotis, Flexion Therapeutics and Nucana Biomed. She was also on the board of Corevalve, Endoart before it was successfully sold to Allergan Inc, of Preglem before the latter was successfully sold to Gedeon Richter and of HBI Ltd before was acquired by Meda.
current job
Rafaele Tordjman
Employee Profiles1
Activity
Recent News4
The graph reveals the ratio (%) of positive news articles in a chosen time range